—Prevention and management of cardiovascular disease in cancer survivors is more complex than in the general public. Javid J. Moslehi, MD, Director of the Cardio ...

Cardio-oncology is especially important today because many powerful cancer treatments, including chemotherapy, radiation, ...

There is growing interest in the cardio-toxic effects of chemotherapy. A key question is when to use imaging. In this video, two leaders in the field of cardio-oncology talk about the role of imaging ...

"One concept to take away is that cardiologists, oncologists, and primary care physicians need to work together to promote cardiovascular health in patients with cancer and in cancer survivors." ...

Please provide your email address to receive an email when new articles are posted on . Several immune checkpoint inhibitors have been approved in the United States and, thus, transformed the ...

Please provide your email address to receive an email when new articles are posted on . The use of immune checkpoint inhibitors to treat various types of cancer appeared linked to severe, inflammatory ...

Researchers studying the side effects of new cancer treatments have determined that patients taking a class of drugs that target the VEGF pathway should be monitored for cardiac issues that include ...

Although the risk for myocarditis related to immune checkpoint inhibitors is an estimated 1%, findings from a recent study highlight the need for improved ways to screen and treat for this potential ...

Please provide your email address to receive an email when new articles are posted on . Results of a pooled meta-analysis presented at last year’s ASCO Annual Meeting and published in Journal of ...

In the first large-scale analysis of cardiovascular complications linked to immune checkpoint inhibitors, Vanderbilt researchers have shown that heart and vessel complications include myocarditis, ...